Trials / Sponsors / Matthew C. Baker
Matthew C. Baker
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Zanubrutinib in Patients With IgG4-Related Disease IgG4 Related Disease | Phase 2 | 2022-08-01 |
| Withdrawn | BAFF/IL-17 Bispecific Antibody Treatment in Subjects With Primary Sjogren's Syndrome Primary Sjogren's Syndrome | Phase 2 / Phase 3 | 2022-02-01 |